Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BBSome interacting protein 1 pseudogene 1 (BBIP1P1) is a **pseudogene**, meaning it is a segment of DNA that resembles a known gene—in this case, the gene encoding BBSome interacting protein 1 (BBIP1, also known as BBS18[5])—but is *not functional* as a protein-coding gene, typically due to mutations or loss of key coding sequences[4]. Pseudogenes are generally classified as nonfunctional remnants of genes, although a small minority have been shown to retain regulatory or non-coding RNA functions in special cases[4][6]. There is no evidence that BBIP1P1 encodes a functional protein or serves as a therapeutic target or receptor. It is not part of any established molecular family such as receptor, enzyme, transporter, or transcription factor. As it is a pseudogene, it is not a direct target for drugs, nor is it implicated as a biomarker or disease-associated gene. The “BBIP1” gene itself, not the pseudogene, encodes a core structural protein of the BBSome complex involved in ciliary function[1][5], but BBIP1P1 is a *non-functional copy* of this gene. Therefore, BBIP1P1 is **not a therapeutic target**.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BBSome interacting protein 1 pseudogene 1 (BBIP1P1).